Alembic Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on April 27, 2015, has recommended a dividend of Rs 3.50 (175%) per Equity Share of face value of Rs 2 each, subject to approval of Shareholders at the ensuing Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.